TRACON Pharmaceuticals (TCON) Short Interest Ratio & Short Volume → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free TCON Stock Alerts $1.81 +0.02 (+1.12%) (As of 02:40 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media TRACON Pharmaceuticals Short Interest DataCurrent Short Volume24,400 sharesPrevious Short Volume744,900 sharesChange Vs. Previous Month-96.72%Dollar Volume Sold Short$43,920.00Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares2,280,000 sharesFloat Size2,100,000 sharesShort Percent of Float1.16%Today's Trading Volume198,388 sharesAverage Trading Volume194,930 sharesToday's Volume Vs. Average102% Short Selling TRACON Pharmaceuticals ? Sign up to receive the latest short interest report for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTCON Short Interest Over TimeTCON Days to Cover Over TimeTCON Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. TRACON Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202424,400 shares $43,920.00 -96.7%1.2%0.1 $1.80 3/31/2024744,900 shares $6.40 million -60.8%N/A0.2 $8.60 3/15/20241,900,000 shares $712,500.00 +323.5%N/A0.7 $0.38 2/29/2024448,700 shares $81,214.70 -47.6%N/A0.2 $0.18 2/15/2024856,300 shares $162,868.26 -29.8%N/A0.5 $0.19 1/31/20241,220,000 shares $235,948.00 +43.0%N/A0.2 $0.19 Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024853,100 shares $144,344.52 -52.3%N/A0.2 $0.17 12/31/20231,790,000 shares $313,429.00 +178.9%N/A0.4 $0.18 12/15/2023641,900 shares $120,035.30 -74.2%N/A0.1 $0.19 11/30/20232,490,000 shares $509,205.00 +23.9%N/A0.6 $0.20 11/15/20232,010,000 shares $340,092.00 +53.4%N/A0.5 $0.17 10/31/20231,310,000 shares $227,547.00 +265.8%N/A1.6 $0.17 10/15/2023358,100 shares $68,755.20 +0.8%N/A0.4 $0.19 9/30/2023355,200 shares $63,225.60 -27.5%N/A0.6 $0.18 9/15/2023489,600 shares $124,358.40 +21.0%N/A0.9 $0.25 8/31/2023404,700 shares $106,840.80 +70.1%N/A0.9 $0.26 8/15/2023237,900 shares $63,995.10 -31.8%N/A0.5 $0.27 7/31/2023348,700 shares $104,923.83 +37.9%N/A1 $0.30 7/15/2023252,800 shares $75,713.60 +78.5%N/A0.8 $0.30 6/30/2023141,600 shares $41,205.60 -37.2%N/A0.5 $0.29 6/15/2023225,300 shares $114,474.93 +38.0%N/A1 $0.51 5/31/2023163,300 shares $94,224.10 +1.4%N/A0.9 $0.58 5/15/2023161,000 shares $104,682.20 -38.7%N/A0.9 $0.65 4/30/2023262,500 shares $207,112.50 +100.7%N/A1.5 $0.79 4/15/2023130,800 shares $253,752.00 +5.7%N/A0.9 $1.94 3/31/2023123,700 shares $233,793.00 +4.1%N/A1.5 $1.89 3/15/2023118,800 shares $180,576.00 -16.7%N/A1.4 $1.52 2/28/2023142,600 shares $219,604.00 -11.1%N/A0.9 $1.54 2/15/2023160,400 shares $267,868.00 -24.6%N/A1.1 $1.67 1/31/2023212,700 shares $357,336.00 -24.6%N/A1.3 $1.68 1/15/2023282,000 shares $502,834.20 -21.3%N/A1.8 $1.78 12/30/2022358,200 shares $533,718.00 +48.8%N/A2.3 $1.49 12/15/2022240,800 shares $308,224.00 +66.9%N/A1.6 $1.28 11/30/2022144,300 shares $217,171.50 -2.8%N/A2 $1.51 11/15/2022148,500 shares $227,205.00 -1.5%N/A2.1 $1.53 10/31/2022150,700 shares $238,106.00 +23.6%N/A2.1 $1.58 10/15/2022121,900 shares $201,135.00 -5.9%N/A1.9 $1.65 9/30/2022129,500 shares $216,265.00 -7.2%N/A2.1 $1.67 9/15/2022139,600 shares $262,448.00 +6.8%N/A2.2 $1.88 8/31/2022130,700 shares $258,786.00 -0.5%N/A2 $1.98Move Your Money Before May 1 (Ad)Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. TCON Short Interest - Frequently Asked Questions What is TRACON Pharmaceuticals' current short interest? Short interest is the volume of TRACON Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 24,400 shares of TCON short. 1.16% of TRACON Pharmaceuticals' shares are currently sold short. Learn More on TRACON Pharmaceuticals' current short interest. What is a good short interest percentage for TRACON Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.16% of TRACON Pharmaceuticals' floating shares are currently sold short. Is TRACON Pharmaceuticals' short interest increasing or decreasing? TRACON Pharmaceuticals saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 24,400 shares, a decrease of 96.7% from the previous total of 744,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TRACON Pharmaceuticals' float size? TRACON Pharmaceuticals currently has issued a total of 2,280,000 shares. Some of TRACON Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRACON Pharmaceuticals currently has a public float of 2,100,000 shares. How does TRACON Pharmaceuticals' short interest compare to its competitors? 1.16% of TRACON Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TRACON Pharmaceuticals: Finch Therapeutics Group, Inc. (1.96%), Palisade Bio, Inc. (4.12%), Fresh Tracks Therapeutics, Inc. (0.17%), Avalon GloboCare Corp. (2.84%), Gamida Cell Ltd. (7.11%), Creative Medical Technology Holdings, Inc. (1.76%), Titan Pharmaceuticals, Inc. (1.72%), TC Biopharm (Holdings) Plc (34.94%), Genetic Technologies Limited (0.41%), Organovo Holdings, Inc. (1.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short TRACON Pharmaceuticals stock? Short selling TCON is an investing strategy that aims to generate trading profit from TRACON Pharmaceuticals as its price is falling. TCON shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TRACON Pharmaceuticals? A short squeeze for TRACON Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCON, which in turn drives the price of the stock up even further. How often is TRACON Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCON, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: FNCH Short Interest PALI Short Interest FRTX Short Interest ALBT Short Interest GMDA Short Interest CELZ Short Interest TTNP Short Interest TCBP Short Interest GENE Short Interest ONVO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCON) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets